Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis – Hospital Healthcare Europe

eczemarelief

11 months ago

Lebrikizumab plus TCS shows sustained disease control in refractory atopic dermatitis Hospital Healthcare Europe

Source link

Previous Article

People with allergies or eczema may face higher risk of surgical complications: Study – Medical Dialogues

Next Article

Eczema awareness campaign launched by actress Tori Spelling and Dr. Adam Friedman – KOKH